Overview Dividends

(SPNS) Sapiens International - Ratings and Ratios

Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: KYG7T16G1039

Insurance, Software, Platform, Consultancy, Reinsurance

SPNS EPS (Earnings per Share)

EPS Growth (3Y CAGR): -56.94%
EPS Trend (3Y Correlation): -34.5%

SPNS Revenue

Revenue Growth (3Y CAGR): 6.53%
Revenue Trend (3Y Correlation): 94.0%

Risk via 10d forecast
Volatility	43.3%
Value at Risk 5%th	49.2%
Relative Tail Risk	-30.87%

Reward TTM
Sharpe Ratio	1.00
Alpha	45.98

Character TTM
Hurst Exponent	0.259
Beta	0.768
Beta Downside	0.683

Drawdowns 3y
Max DD	39.67%
Mean DD	12.01%
Median DD	7.93%

Description: SPNS Sapiens International November 13, 2025

Sapiens International Corp. (NASDAQ: SPNS) develops and sells cloud-native software for insurers across property-and-casualty, life & pensions, and reinsurance markets in North America, Europe and beyond. Its flagship offerings include IDIT Suite (AI-driven end-to-end processing), Digital Suite (customer-facing engagement), Core Suite (policy administration), CustomerConnect/AgentConnect portals, and ReinsuranceMaster for automated reinsurance workflow.

In FY 2023 the company generated $618 million in revenue, with subscription-based ARR expanding at roughly 20% YoY and subscription revenue now representing about 70% of total sales-metrics that underscore the shift toward recurring-revenue models in insurance tech. Growth is being propelled by macro-level drivers such as accelerated digital transformation in the insurance sector (projected 13% CAGR for cloud adoption through 2029) and heightened regulatory pressure for real-time data analytics, both of which favor AI-enabled platforms like Sapiens.

For a deeper, data-driven valuation perspective, you may find ValueRay’s analyst platform worth exploring.

SPNS Stock Overview

Market Cap in USD	2,412m
Sub-Industry	Application Software
IPO / Inception	1992-05-29
Return 12m vs S&P 500	35.4%
Analyst Rating	2.80 of 5

SPNS Dividends

Dividend Yield	1.53%
Yield on Cost 5y	2.47%
Yield CAGR 5y	42.05%
Payout Consistency	78.3%
Payout Ratio	61.1%

SPNS Growth Ratios

CAGR 3y	34.31%
CAGR/Max DD Calmar Ratio	0.87
CAGR/Mean DD Pain Ratio	2.86
Current Volume	275.1k
Average Volume	348.2k

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (68.4m TTM) > 0 and > 6% of Revenue (6% = 32.9m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA 0.88pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 11.86% (prev 31.17%; Δ -19.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.11 (>3.0%) and CFO 82.4m > Net Income 68.4m (YES >=105%, WARN >=100%)

Net Debt (-19.2m) to EBITDA (102.1m) ratio: -0.19 <= 3.0 (WARN <= 3.5)

Current Ratio 1.37 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (56.1m) change vs 12m ago -0.17% (target <= -2.0% for YES)

Gross Margin 44.26% (prev 43.69%; Δ 0.57pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 78.03% (prev 79.79%; Δ -1.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 206.2 (EBITDA TTM 102.1m / Interest Expense TTM 395.0k) >= 6 (WARN >= 3)

Altman Z'' 2.68

(A) 0.09 = (Total Current Assets 239.8m - Total Current Liabilities 174.7m) / Total Assets 739.6m

(B) 0.22 = Retained Earnings (Balance) 160.2m / Total Assets 739.6m

(D) 0.59 = Book Value of Equity 134.1m / Total Liabilities 227.5m

Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 78.73

1. Piotroski 7.50pt = 2.50

2. FCF Yield 3.02% = 1.51

3. FCF Margin 13.11% = 3.28

4. Debt/Equity 0.09 = 2.50

5. Debt/Ebitda -0.19 = 2.50

6. ROIC - WACC (= 7.95)% = 9.93

7. RoE 14.32% = 1.19

8. Rev. Trend 93.98% = 7.05

9. EPS Trend -34.55% = -1.73

What is the price of SPNS shares?

As of November 15, 2025, the stock is trading at USD 43.18 with a total of 275,115 shares traded.
Over the past week, the price has changed by +0.07%, over one month by +0.21%, over three months by +1.20% and over the past year by +55.18%.

Is Sapiens International a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Sapiens International (NASDAQ:SPNS) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 78.73 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SPNS is around 46.95 USD . This means that SPNS is currently overvalued and has a potential downside of 8.73%.

Is SPNS a buy, sell or hold?

Sapiens International has received a consensus analysts rating of 2.80. Therefor, it is recommend to hold SPNS.

Strong Buy: 0
Buy: 1
Hold: 2
Sell: 2
Strong Sell: 0

What are the forecasts/targets for the SPNS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	37.3	-13.7%
Analysts Target Price	37.3	-13.7%
ValueRay Target Price	52.5	21.5%

SPNS Fundamental Data Overview November 11, 2025

Market Cap USD = 2.41b (2.41b USD * 1.0 USD.USD)
P/E Trailing = 35.3689
P/E Forward = 29.5858
P/S = 4.3934
P/B = 4.8249
P/EG = 5.9208
Beta = 0.901
Revenue TTM = 549.0m USD
EBIT TTM = 81.4m USD
EBITDA TTM = 102.1m USD
Long Term Debt = 19.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = 27.1m USD (from shortTermDebt, last quarter)
Debt = 45.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -19.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.38b USD (2.41b + Debt 45.4m - CCE 74.5m)
Interest Coverage Ratio = 206.2 (Ebit TTM 81.4m / Interest Expense TTM 395.0k)
FCF Yield = 3.02% (FCF TTM 72.0m / Enterprise Value 2.38b)
FCF Margin = 13.11% (FCF TTM 72.0m / Revenue TTM 549.0m)
Net Margin = 12.45% (Net Income TTM 68.4m / Revenue TTM 549.0m)
Gross Margin = 44.26% ((Revenue TTM 549.0m - Cost of Revenue TTM 306.0m) / Revenue TTM)
Gross Margin QoQ = 43.71% (prev 44.57%)
Tobins Q-Ratio = 3.22 (Enterprise Value 2.38b / Total Assets 739.6m)
Interest Expense / Debt = 0.87% (Interest Expense 395.0k / Debt 45.4m)
Taxrate = 20.37% (3.68m / 18.1m)
NOPAT = 64.8m (EBIT 81.4m * (1 - 20.37%))
Current Ratio = 1.37 (Total Current Assets 239.8m / Total Current Liabilities 174.7m)
Debt / Equity = 0.09 (Debt 45.4m / totalStockholderEquity, last quarter 498.3m)
Debt / EBITDA = -0.19 (Net Debt -19.2m / EBITDA 102.1m)
Debt / FCF = -0.27 (Net Debt -19.2m / FCF TTM 72.0m)
Total Stockholder Equity = 477.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.24% (Net Income 68.4m / Total Assets 739.6m)
RoE = 14.32% (Net Income TTM 68.4m / Total Stockholder Equity 477.5m)
RoCE = 16.38% (EBIT 81.4m / Capital Employed (Equity 477.5m + L.T.Debt 19.8m))
RoIC = 16.66% (NOPAT 64.8m / Invested Capital 389.3m)
WACC = 8.71% (E(2.41b)/V(2.46b) * Re(8.86%) + D(45.4m)/V(2.46b) * Rd(0.87%) * (1-Tc(0.20)))
Discount Rate = 8.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.14%
[DCF Debug] Terminal Value 76.96% ; FCFE base≈66.8m ; Y1≈74.1m ; Y5≈96.9m
Fair Price DCF = 25.90 (DCF Value 1.45b / Shares Outstanding 55.9m; 5y FCF grow 12.65% → 3.0% )
EPS Correlation: -34.55 | EPS CAGR: -56.94% | SUE: -4.0 | # QB: 0
Revenue Correlation: 93.98 | Revenue CAGR: 6.53% | SUE: 0.98 | # QB: 1

Additional Sources for SPNS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle